MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
All News
Headline News
Press Releases
< Previous 1 2
...
30 31 32 33 34 35 36 37 38
...
99 100 Next >
Rocket Lab and Synspective Strike Another 10-Launch Deal, Boosting Contracted Missions to 21 Electron Launches
From Rocket Lab Corporation
Via GlobeNewswire
Tickers RKLB
Megan Holdings Limited Announces Closing of $5 Million Initial Public Offering
From Megan Holdings Limited
Via GlobeNewswire
Phoenix Energy Announces Closing of Preferred Share Initial Public Offering and Expected Date for Trading on NYSE American
From Phoenix Energy One, LLC
Via GlobeNewswire
ONEOK to Participate in Investor Conference
From ONEOK
Via GlobeNewswire
Tickers OKE
FAIRCHILD TO ACQUIRE 100% OF ADVANCED STAGE GOLDEN ARROW PROJECT FURTHER EXPANDING ITS FOOTPRINT ON THE WALKER LANE SHEAR ZONE REGION OF NEVADA
From Fairchild Gold Corp.
Via GlobeNewswire
Tickers TSX-V:FAIR
Lesaka’s Final FY2025 Results: Delivers on FY2025 Profitability Guidance, Reaffirms FY2026 Profitability & Net Revenue Outlook, and Sets FY2026 Profitability per Share Guidance, reflecting more than 100% Year-on-Year Growth
From Lesaka Technologies
Via GlobeNewswire
Tickers LSAK
Sunrise Secures U.S. Patent for Advanced Lithium-Ion Battery Anode Material Preparation Method, Strengthening Its Leading Position in the United States
From Sunrise New Energy Co., Ltd
Via GlobeNewswire
Tickers EPOW
Experior Financial Group Announces Strategic Alliance with Associate Owners Group Inc.
From Experior Financial Group
Via GlobeNewswire
Anaptys Announces Intent to Separate Biopharma Operations from Substantial Royalty Assets by Year-end 2026
From AnaptysBio, Inc.
Via GlobeNewswire
Tickers ANAB
Anaptys to Provide Overview of ANB033, a CD122 antagonist, at Virtual Investor Event on Tuesday, Oct. 14
From AnaptysBio, Inc.
Via GlobeNewswire
Tickers ANAB
Abivax Announces Acceptance of Additional Late-Breaking Abstract from the ABTECT Phase 3 Induction Trials to be Presented at 2025 United European Gastroenterology (UEG) Meeting
From Abivax
Via GlobeNewswire
Tickers ABVX
ARS Pharmaceuticals Secures Up to $250 Million Loan Facility with RA Capital Management and OMERS Life Sciences to Accelerate U.S. Commercialization of neffy®
From ARS Pharmaceuticals, Inc.
Via GlobeNewswire
Tickers SPRY
Aimfinity Investment Corp. I Announces New Monthly Extension for Business Combination
From Aimfinity Investment Corp. I
Via GlobeNewswire
Tickers AIMAU AIMTF
uniQure Announces Closing of Upsized Public Offering and Full Exercise by Underwriters of Option to Purchase Additional Shares
From uniQure Inc.
Via GlobeNewswire
Tickers QURE
Alameda Health System is recognized as one of Newsweek’s America’s Best Nursing Homes 2026
From Alameda Health System
Via GlobeNewswire
SciSparc: N2OFF Shareholders Approve Merger with SciSparc’s Majority Owned Subsidiary MitoCareX, a Drug Discovery Company Targeting Resistant Cancers Including Pancreatic and Non-Small Cell Lung Cancer
From SciSparc Ltd
Via GlobeNewswire
Tickers SPRC
Progress Software Announces Third Quarter 2025 Financial Results
From Progress Software Corporation
Via GlobeNewswire
Tickers PRGS
Metsera Reports Positive Phase 2b Results for First- and Best-in-Class Ultra-long Acting GLP-1 RA Candidate MET-097i, Enabling Rapid Transition into Phase 3
From Metsera, Inc.
Via GlobeNewswire
Tickers MTSR
Septerna Appoints Veteran Biotechnology Leader Keith Gottesdiener, M.D., to its Board of Directors
From Septerna, Inc.
Via GlobeNewswire
Tickers SEPN
Arcutis Biotherapeutics to Host Virtual Investor Day and Report Third Quarter 2025 Financial Results on October 28, 2025
From Arcutis Biotherapeutics, Inc.
Via GlobeNewswire
Tickers ARQT
SLNO Investor News: If You Have Suffered Losses in Soleno Therapeutics, Inc. (NASDAQ: SLNO), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
From The Rosen Law Firm PA
Via GlobeNewswire
Tickers SLNO
TLX Investor News: If You Have Suffered Losses in Telix Pharmaceuticals Ltd. (NASDAQ: TLX), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
From The Rosen Law Firm PA
Via GlobeNewswire
Tickers TLX
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Semler Scientific, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – SMLR
From The Rosen Law Firm PA
Via GlobeNewswire
Tickers SMLR
Silo Pharma Updates Strategic Agreement with Fireblocks to Secure Crypto Treasury Management
From Silo Pharma, Inc.
Via GlobeNewswire
Tickers SILO
Byline Bank Announces Sponsorship of Chicago Blackhawks
From Byline Bank
Via GlobeNewswire
Tickers BY
TechSmith Announces Inaugural TechSmith Unlocked Virtual Conference
From TechSmith Corporation
Via GlobeNewswire
OxyCon 2025 to Address the Future of Web Access
From Oxylabs
Via GlobeNewswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates EA, MRUS, BRY, SMLR on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
Tickers BRY EA MRUS SMLR
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PINC, MTSR, HOUS, ODP on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
Tickers HOUS MTSR ODP PINC
The 2025 Ordos Annual Conference on Media Convergence Development is about to commence: Showcasing practical achievements in media convergence to the world
From Organizing Committee of the 2025 Ordos Annual Conference on Media Convergence Development
Via GlobeNewswire
< Previous 1 2
...
30 31 32 33 34 35 36 37 38
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
TOP
Email a Story